GlassScriptPhysician profile
Florence Jean-Louis
NPI 1013943547
$778.39
in general payments reported to CMS, 2019-2025
12 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.24 · 2020: $148 · 2021: $216 · 2022: $20.85 · 2023: $104 · 2024: $64.73 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $282.48 | 2019-2025 | |
| Novo Nordisk INC | $174.79 | 2021 | |
| Therapeuticsmd, INC. | $56.38 | 2020-2022 | |
| Shield Therapeutics INC | $53.30 | 2025 | |
| Exeltis, USA INC. | $41.76 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $33.42 | 2023 | |
| Astellas Pharma US INC | $33.34 | 2023-2024 | Veozah |
| Pfizer INC. | $31.59 | 2023-2024 | |
| Hologic Sales and Service, LLC | $23.59 | 2025 | Aptima |
| Sumitomo Pharma America, INC. | $20.71 | 2024 | Myfembree |
| Exact Sciences Corporation | $14.14 | 2024 | Cologuard Collection Kit |
| Baxter Healthcare | $12.89 | 2023 | Floseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florence Jean-Louis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.